Targeting OX40-OX40L pathway: A new era in atopic dermatitis management by T cell rebalancing
1. 系统已在2025-04-18 11:34:18对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
S Nakajima, S Yonekura…
The Journal of allergy …, 2025
pubmed.ncbi.nlm.nih.gov
Targeting OX40-OX40L pathway: A new era in atopic dermatitis management by T cell rebalancing Targeting OX40-OX40L pathway: A new era in atopic dermatitis management by T cell rebalancing J Allergy Clin Immunol. 2025 Feb 18:S0091-6749(25)00174-5. doi: 10.1016/j.jaci.2025.02.007. Online ahead of print. Authors Saeko Nakajima 1 , Satoru Yonekura 2 , Kenji Kabashima 3 Affiliations 1 Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Department of Drug Discovery for Inflammatory Skin Diseases, Kyoto …
